{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T09:57:52Z","timestamp":1767866272487,"version":"3.49.0"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,1,4]]},"DOI":"10.1097\/wnr.0b013e32834d92e6","type":"journal-article","created":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T07:44:28Z","timestamp":1320133468000},"page":"10-15","source":"Crossref","is-referenced-by-count":13,"title":["Reagents that block neuronal death from Huntington\u2019s disease also curb oxidative stress"],"prefix":"10.1097","volume":"23","author":[{"given":"Antonio","family":"Valencia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen","family":"Sapp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick B.","family":"Reeves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Masso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly B.","family":"Kegel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marian","family":"DiFiglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-3-20210201","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00005072-199805000-00001","article-title":"Huntington disease.","volume":"57","author":"Vonsattel","year":"1998","journal-title":"J Neuropathol Exp Neurol"},{"key":"R2-3-20210201","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1212\/WNL.38.3.341","article-title":"Clinical and neuropathologic assessment of severity in Huntingtons disease.","volume":"38","author":"Myers","year":"1988","journal-title":"Neurology"},{"key":"R3-3-20210201","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","article-title":"Neuropathological classification of Huntingtons disease.","volume":"44","author":"Vonsattel","year":"1985","journal-title":"J Neuropathol Exp Neurol"},{"key":"R4-3-20210201","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1212\/WNL.41.7.1117","article-title":"Morphometric analysis of the prefrontal cortex in Huntingtons disease.","volume":"41","author":"Sotrel","year":"1991","journal-title":"Neurology"},{"key":"R5-3-20210201","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1196\/annals.1427.008","article-title":"Evidence of oxidant damage in Huntingtons disease: translational strategies using antioxidants.","volume":"1147","author":"Stack","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"R6-3-20210201","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0006-8993(00)02082-5","article-title":"Striatal oxidative damage parallels the expression of a neurological phenotype in mice transgenic for the mutation of Huntingtons disease.","volume":"862","author":"Perez-Severiano","year":"2000","journal-title":"Brain Res"},{"key":"R7-3-20210201","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1046\/j.1471-4159.2001.00689.x","article-title":"Increased oxidative damage to DNA in a transgenic mouse model of Huntingtons disease.","volume":"79","author":"Bogdanov","year":"2001","journal-title":"J Neurochem"},{"key":"R8-3-20210201","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0304-3940(01)02326-6","article-title":"Coenzyme Q10 and remacemide hydrochloride ameliorate motor deficits in a Huntingtons disease transgenic mouse model.","volume":"315","author":"Schilling","year":"2001","journal-title":"Neurosci Lett"},{"key":"R9-3-20210201","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1111\/j.1471-4159.2009.06074.x","article-title":"Combination therapy with coenzyme Q10 and creatine produces additive neuroprotective effects in models of Parkinsons and Huntingtons diseases.","volume":"109","author":"Yang","year":"2009","journal-title":"J Neurochem"},{"key":"R10-3-20210201","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.neuroscience.2008.08.041","article-title":"Extensive early motor and non-motor behavioral deficits are followed by striatal neuronal loss in knock-in Huntingtons disease mice.","volume":"157","author":"Hickey","year":"2008","journal-title":"Neuroscience"},{"key":"R11-3-20210201","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/cne.10776","article-title":"Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntingtons disease with 140 CAG repeats.","volume":"465","author":"Menalled","year":"2003","journal-title":"J Comp Neurol"},{"key":"R12-3-20210201","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/jnr.22184","article-title":"Mutant huntingtin and glycogen synthase kinase 3-beta accumulate in neuronal lipid rafts of a presymptomatic knock-in mouse model of Huntingtons disease.","volume":"88","author":"Valencia","year":"2010","journal-title":"J Neurosci Res"},{"key":"R13-3-20210201","doi-asserted-by":"crossref","first-page":"4552","DOI":"10.1523\/JNEUROSCI.5865-09.2010","article-title":"Aberrant Rab11-dependent trafficking of the neuronal glutamate transporter EAAC1 causes oxidative stress and cell death in Huntingtons disease.","volume":"30","author":"Li","year":"2010","journal-title":"J Neurosci"},{"key":"R14-3-20210201","doi-asserted-by":"crossref","first-page":"14708","DOI":"10.1523\/JNEUROSCI.1637-10.2010","article-title":"BDNF overexpression in the forebrain rescues Huntingtons disease phenotypes in YAC128 mice.","volume":"30","author":"Xie","year":"2010","journal-title":"J Neurosci"},{"key":"R15-3-20210201","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1523\/JNEUROSCI.5113-06.2007","article-title":"Brain-derived neurotrophic factor restores synaptic plasticity in a knock-in mouse model of Huntingtons disease.","volume":"27","author":"Lynch","year":"2007","journal-title":"J Neurosci"},{"key":"R16-3-20210201","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1111\/j.1742-4658.2006.05318.x","article-title":"Analysis of oxidative events induced by expanded polyglutamine huntingtin exon 1 that are differentially restored by expression of heat shock proteins or treatment with an antioxidant.","volume":"273","author":"Firdaus","year":"2006","journal-title":"FEBS J"},{"key":"R17-3-20210201","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1750-3639.2007.00111.x","article-title":"Systematic assessment of BDNF and its receptor levels in human cortices affected by Huntingtons disease.","volume":"18","author":"Zuccato","year":"2008","journal-title":"Brain Pathol"},{"key":"R18-3-20210201","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1460-9568.2006.04590.x","article-title":"Reduced expression of the TrkB receptor in Huntingtons disease mouse models and in human brain.","volume":"23","author":"Gines","year":"2006","journal-title":"Eur J Neurosci"},{"key":"R19-3-20210201","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1111\/j.1471-4159.2008.05864.x","article-title":"The CREBCRE transcriptional pathway: protection against oxidative stress-mediated neuronal cell death.","volume":"108","author":"Lee","year":"2009","journal-title":"J Neurochem"},{"key":"R20-3-20210201","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1093\/hmg\/11.9.1137","article-title":"Heat shock protein 27 prevents cellular polyglutamine toxicity and suppresses the increase of reactive oxygen species caused by huntingtin.","volume":"11","author":"Wyttenbach","year":"2002","journal-title":"Hum Mol Genet"},{"key":"R21-3-20210201","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1006\/exnr.2000.7626","article-title":"Early degenerative changes in transgenic mice expressing mutant huntingtin involve dendritic abnormalities but no impairment of mitochondrial energy production.","volume":"169","author":"Guidetti","year":"2001","journal-title":"Exp Neurol"},{"key":"R22-3-20210201","doi-asserted-by":"crossref","first-page":"30773","DOI":"10.1074\/jbc.M504749200","article-title":"Mitochondrial respiration and ATP production are significantly impaired in striatal cells expressing mutant huntingtin.","volume":"280","author":"Milakovic","year":"2005","journal-title":"J Biol Chem"}],"container-title":["NeuroReport"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00001756-201201040-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T02:08:20Z","timestamp":1618279700000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001756-201201040-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,4]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/wnr.0b013e32834d92e6","relation":{},"ISSN":["0959-4965"],"issn-type":[{"value":"0959-4965","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1,4]]}}}